Actively Recruiting

Phase 4
Age: 18Years - 50Years
FEMALE
ID06925152

COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block

Led by University of Tennessee · Updated on 2026-03-11

120

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Tennessee

Lead Sponsor

R

Regional One Health

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating how intraoperative transversus abdominis plane (TAP) blocks affect the amount of opioid pain medication needed after cesarean delivery during complex obstetric surgery. This study focuses on whether using bupivacaine in TAP blocks can reduce opioid use and improve pain control following surgery. The trial aims to fill gaps in understanding the role of TAP blocks specifically for high-risk or complicated cesarean deliveries. Participants are randomly assigned to one of two groups: one receives a TAP block with 0.5% bupivacaine mixed with saline, and the other receives a placebo TAP block with saline only. The TAP blocks are applied during surgery, and the study compares opioid consumption and pain outcomes between these groups. The trial uses a quadruple-blind design to ensure unbiased results. During the study, researchers will track opioid pain medication usage between 24 and 48 hours after surgery as the primary outcome. They will also look at opioid use within the first 24 hours and up to one week, assess daily living activities after one week, and monitor unplanned postoperative visits for six months. Additional data on patients' geographic regions will be collected to explore diversity and inclusion. Participants' pain, opioid use, and recovery will be carefully monitored throughout the study period, which lasts up to six months post-surgery.

CONDITIONS

Brief Title

COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block

Who Can Participate

Age: 18Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient has a history of at least one of the following:
  • Prior exploratory laparotomy
  • History of non-obstetric open intra-abdominal surgery
  • History of three or more prior cesarean deliveries
  • History of intra-abdominal or pelvic adhesive disease
  • History of abdominoplasty
  • History of abdominal re-exploration surgery
  • Female aged 18 to 50 years
Not Eligible

You will not qualify if you...

  • Received general anesthesia
  • History of fewer than three cesarean deliveries if other inclusion criteria are not met
  • History of chronic opioid use
  • History of substance abuse (alcohol, methamphetamine/amphetamine, prescription opioid abuse, or heroin use)
  • History of chronic kidney disease
  • Allergies to bupivacaine or oral analgesics
  • Patient preference not to participate
  • Cesarean hysterectomy
  • Administration of 4 mg or more morphine to epidural
  • Loss to follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Day of surgery

Participants undergo complex cesarean delivery surgery during which an intraoperative TAP block with either bupivacaine or placebo is administered to manage postoperative pain.

1 surgical visit (in-person)

Follow-up

Duration - Up to 6 months post-surgery

Participants are monitored for postoperative pain medication use, functional recovery, and any unplanned postoperative visits over several weeks to months after surgery.

Multiple follow-up visits including assessments at 24 hours, 48 hours, 1 week, and up to 6 months postoperatively

Trial Site Locations

Total: 1 location

1

Regional One Health

Memphis, Tennessee, United States, 38103

Actively Recruiting

Loading map...

Research Team

M

Michael VanDillen Fellow physician, PI of study, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Labor Induction in Low-risk Women at 39 Weeks of Gestation: ...

Cesarean Delivery

Actively Recruiting

1 location

Azithromycin Prophylaxis for Prelabor Cesarean Delivery Tria...

Obstetrical Complications

Actively Recruiting

14 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial.

John G McDonnell, Brian O'Donnell, Gerard Curley...

https://pubmed.ncbi.nlm.nih.gov/17179269

Clinical effectiveness of transversus abdominis plane (TAP) block in abdominal surgery: a systematic review and meta-analysis.

N Johns, S O'Neill, N T Ventham...

https://pubmed.ncbi.nlm.nih.gov/22632762

Efficacy of Single Wound Infiltration With Bupivacaine and Adrenaline During Cesarean Delivery for Reduction of Postoperative Pain: A Randomized Clinical Trial.

Gali Garmi, Mark Parasol, Noah Zafran...

https://pubmed.ncbi.nlm.nih.gov/36378307

Transversus abdominis plane block for postoperative analgesia after Caesarean delivery performed under spinal anaesthesia? A systematic review and meta-analysis.

F W Abdallah, S H Halpern, C B Margarido

https://pubmed.ncbi.nlm.nih.gov/22907337